We compared the diagnostic performances and unnecessary fnA rates of several guidelines and modified versions using the size threshold of the ACR TIRADS. Our Institutional Review Board approved this retrospective study and waived the requirement for informed consent and all methods were performed in accordance with the Declaration of Helsinki. A total of 1,384 thyroid nodules in 1,301 patients with definitive cytopathologic findings were included. US categories were assigned according to each guideline. We applied the size threshold suggested by the ACR TIRADS for FNA to the Kwak, ATA and EU guidelines and defined these modified guidelines as the modified Kwak (mKwak), modified ATA (mATA) and modified EU (mEU) guidelines. Diagnostic performances and unnecessary FNA rates of all guidelines were evaluated. Of 1,384 thyroid nodules, 291 (21%) were malignant. Among the original guidelines, the ACR TIRADS had the highest specificity, accuracy, LR and AUC (62.2%, 66%, 2.128 and 0.713). The mKwak, mATA and mEU guidelines had higher specificity, accuracy, LR and AUC (P < 0.001 for all), and fewer unnecessary FNAs, compared with their original guidelines. Among all original and modified guidelines, the mKwak guideline had the highest specificity, accuracy, LR and AUC (64%, 68.6%, 2.389 and 0.75). The unnecessary FNA rate was the lowest with the mKwak guideline (61.1%). The highest sensitivity was observed with the ATA guideline (98.6%). After incorporating the size threshold of the ACR TIRADS to other TIRADS, all guidelines showed higher diagnostic accuracy and lower unnecessary FNA rates than their original versions. The mKwak guideline showed the best diagnostic performances. Thyroid ultrasonography (US) is now regularly performed in clinical practice and thyroid nodules are exceedingly common on US with as many as 68% of adults having one, leading to issues of overdiagnosis and overtreatment 1,2. Many guidelines recommend fine-needle aspiration (FNA) based on several risk stratification systems which use different US features and even different size thresholds 3-7. Current risk stratification systems using US features can be broadly divided into two types: the point-scale Thyroid Imaging Reporting and Data System (TIRADS) suggested by Kwak et al. 8 , Park et al. 9 and the American College of Radiology (ACR) 3 and the pattern-recognition TIRADS suggested by Horvath et al. 10 , the 2015 American Thyroid Association (ATA) 7 , and European Thyroid Association (EU) 11. Different size criteria have been suggested by the ATA guideline, ACR and EU TIRADS 3,7,11. Although there are many guidelines for recommending FNA for thyroid nodules on US, a worldwide communicable system does not presently exist. Recently, Grani et al. 12 demonstrated that the ACR TIRADS reduced unnecessary FNAs more than other international guidelines with a very low false-negative rate (2.2%, 6/268). The ACR TIRADS suggests a higher size threshold for FNA than other guidelines while still recommending similar malignancy risks for each final assessment ca...